Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
NAMS
Stock Latest News
The Fly
NewAmsterdam Pharma price target raised to $41 from $35 at Guggenheim
1M ago
NAMS
Premium
Ratings
NewAmsterdam Pharma: Buy Rating Backed by Promising Obicetrapib Trials and Strong Financial Position
1M ago
NAMS
Premium
The Fly
NewAmsterdam Pharma files $500M mixed securities shelf
1M ago
NAMS
Premium
Company Announcements
NewAmsterdam Pharma’s 2024 Financial Results and Clinical Progress
1M ago
NAMS
Premium
The Fly
NewAmsterdam Pharma price target raised to $52 from $47 at Scotiabank
2M ago
NAMS
Premium
Company Announcements
Newamsterdam Pharma Faces Potential Investor Risks Due to Shareholder Influence
2M ago
NAMS
Premium
Ratings
Promising Outlook for NewAmsterdam Pharma: Buy Rating Affirmed Amid Successful Trials and Strong Financial Position
2M ago
NAMS
Premium
Ratings
Promising Drug Developments and Positive Trial Results Drive Buy Rating for NewAmsterdam Pharma
2M ago
NAMS
Premium
The Fly
NewAmsterdam reports FY24 revenue $45.56M, consensus $31.13M
2M ago
NAMS
Premium
Company Announcements
NewAmsterdam Pharma Achieves Key Milestones in 2024
3M ago
8K
NAMS
Premium
The Fly
NewAmsterdam Pharma outlines 2025 strategic priorities
3M ago
NAMS
Premium
The Fly
Annexon appoints William Jones to board of directors
3M ago
ANNX
NAMS
Premium
The Fly
Boeing slips after Jeju Air crash, HashiCorp-IBM draws review: Morning Buzz
3M ago
T
BA
Premium
The Fly
American Air upgraded, Nordstrom downgraded: Wall Street’s top analyst calls
3M ago
AAL
JWN
Premium
The Fly
NewAmsterdam Pharma initiated with a Buy at H.C. Wainwright
3M ago
NAMS
Premium
The Fly
Esperion initiated with an Overweight at Cantor Fitzgerald
4M ago
ESPR
NAMS
Premium
The Fly
Menarini announces topline data from Phase 3 BROADAY, TANDEM trials
4M ago
NAMS
Premium
Company Announcements
NewAmsterdam Pharma’s $452.6M Public Offering Success
4M ago
8K
NAMS
Premium
The Fly
NewAmsterdam Pharma 12.12M share Secondary priced at $24.50
4M ago
NAMS
Premium
The Fly
Esperion selloff continues following competitor data from NewAmsterdam
4M ago
ESPR
NAMS
Premium
The Fly
NewAmsterdam Pharma price target raised to $47 from $35 at Scotiabank
4M ago
NAMS
Premium
The Fly
NewAmsterdam Pharma announces $300M offering of ordinary shares, warrants
4M ago
NAMS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
